The differential diagnosis algorithms of hypertrophic cardiomyopathy and hypertrophic cardiomyopathy syndromes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The differential diagnosis in HCM patients is discussed. Literature data and results of 98 hypertrophic cardiomyopathy patients examination are given. The differential diagnosis algorithms for HCM and HCM syndromes are proposed.

Full Text

Restricted Access

About the authors

Marina Vitalyevna Turalchuk

St.Petersburg State Pediatric Medical University

Email: ten_puppies@mail.ru
MD, PhD, Assistant Professor. Pediatrics Dept. named after Professor I. M. Voroncov, Faculty of Postgraduate Education

Gennadiy Ayzikovich Novik

St.Petersburg State Pediatric Medical University

Email: ga_novik@mail.ru
MD, PhD, Dr Med Sci, Professor, Head, Pediatrics Dept. named after Professor I. M. Voroncov, Faculty of Postgraduate Education

Aleksandra Yakovlevna Goodkova

St. Petersburg State Medical University n. a. acad. I.P. Pavlov

Email: alexagood-1954@mail.ru
MD, PhD, Dr Med Sci, Professor, Head Laboratory of cardiomyopathies

References

  1. Chimenti C., Pieroni M. et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy // Circulation. — 2004. — Vol. 110 (9). — P. 1047–1053.
  2. Colan Steven D., Lipshultz Steven E., Lowe April M. et al. Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children Findings From the Pediatric Cardiomyopathy Registry // Circulation — 2007. — Vol. 115. — P. 773–781
  3. Gersh B. J., Maron B. J., Bonow R. O., Dearni J. A. et al. 2011 ACCF/AHA Guideline for Diagnosis and Treatment of Hypertrophic cardiomyopathy // Circ. published online November 8, 2011.
  4. Hoffmann B., Mayatepek E. Fabry disease-often seen, rarely diagnosed // Dtsch Arztebl. Int. — 2009. — Vol. 106 (26). — P. 440–447.
  5. Keren Andre, Syrris Petros, McKenna William J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression // Nature clinical practice cardiovascular medicine. — 2008. — Vol.5. — P. 158–168.
  6. Maron B., McKenna J. et al. ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy // JACC. — 2003. — Vol. 42. — P. 1–27.
  7. Maron Barry J., Seidman Christine E. et al. How should hypertrophic cardiomyopathy be classified? // Circ. Cardiovasc Genet. — 2009. — Vol. 2. — P. 81–86.
  8. Veinot J. P. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy // Circulation. — 2002. — Vol. 106 (15). — P. 1407–1411.
  9. Wilkinson James D. et al. The Pediatric Cardiomyopathy Registry: 1995–2007 // Prog. Pediatr. Cardiol. — 2008. — Vol. 25 (1). — P. 31–36.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Turalchuk M.V., Novik G.A., Goodkova A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies